UK Markets close in 7 hrs 45 mins

Merck & Co., Inc. (MRK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
78.67-1.16 (-1.45%)
At close: 4:02PM EDT
Sign in to post a message.
  • e
    ed
    Well I started at $79.06. I sold my position in the mid $80’s last month after buying MRK during the March plunge. I just think it got too cheap to pass. I would add on further weakness. I think the price of MRK is absurd. I am sure a Biden win has the stock shaky but worse seems to be priced in.
  • R
    Ryan
    Of all my stocks I feel this one is the one that will break out next on the upside even in a sideways market. It’s been in a 24 month consolidation pattern. Well run company that has a decent pipeline with good cash flows.
  • P
    Peter
    Hi all, went long here with £13K about a month ago @85.ish. Got 1 year with free financing. Was happy to think a 10% gain was possible. Any thoughts that is a maybe, I’ve got till September. Bit disappointed @ mo. Did loads of looking into different possibles & took a punt on MRK. Only 10% please 🥴)). Have a good day all, pete.
  • F
    Frank
    Merck has great scientists, however I'm very disappointed with Merck's market performance while the market is going up.
  • A
    ALBERT
    Trying to stay strong here, but can’t understand this downturn.
  • P
    Peter
    Hi all, it’s been all over the news here in the UK. That the BCG vaccine is being looked into for COVID-19 treatment. On quick search found that MRK is a big player in BCG. Any thoughts if this big for us? Pete.
  • J
    Joe
    What is story with their covid treatment ?
  • f
    funny
    The CEO needs to go. He does not focus on running the campany business, instead, he talks about politics. But he is good for neither.
  • T
    The Chewdog
    While the stock price continues to fall MRK made sure they got their corporate responsibility data published.
    New leadership is clearly needed
  • T
    The Chewdog
    MRK is like a boat adrift in the ocean—-no direction
  • B
    Brent
    Must be an algorithm attacking higher dividend paying stocks. MRK, however, is crushing it as proven by its last eps report. Either that or Frazier's helter-skelter guidance is scaring investors away.
  • S
    Soopa
    Well... looks like MRK finally getting in on some vaccine clinical trials

    www.clinicaltrials.gov/ct2/show/NCT04569786
  • A
    Anonymous
    So when does MRK get a competent CEO and Management team? PC choices not cutting it in the stock market.
  • J
    Joe
    And Merck would know! They used a modified herpes vaccine injected directly into my tumors to get my immune system to respond aggressively along with 2 yrs of keytruda and I had aggressive stage 4 cancer tumors were literally everywhere-healthy as a horse today 3 yrs and few months after first diagnosis thank you Merck and thank God!
  • B
    Brad
    Below 80 looks like a good time to load up.
  • T
    Traves
    USA Praying for everyone and MRNA PFE ABBY ABT BMY JNJ and More
    Hope we do well with Micro-Cap (ACOR) Pennies to Riches - Soon I hope
  • a
    ageninrussia
    vibostolimab anti-TIGIT $MRK

    No monotherapy activity (P1 escalation).

    Ran the expansion phase 1 in PD-1/PD-L1 naive NSCLC + pembro.

    does not appear to be much better than pembro alone
  • A
    Anonymous
    Without covid, MRK is still a strong company. $80 is a good support. $85 is a short high unless there is surprising news.
  • A
    Anonymous
    CEO not getting it done so far! Stock performance reflects lack of direction.
  • T
    Traves
    Jack and Jill - advise ACOR